Treatment of multiple sclerosis with laquinimod

Details for Australian Patent Application No. 2010260455 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Tarcic, Nora; Bar-Zohar, Dan; Kofler, Dina

Agent FB Rice

Pub. Number AU-A-2010260455

PCT Pub. Number WO2010/147665

Priority 61/269,070 19.06.09 US

Filing date 18 June 2010

Wipo publication date 23 December 2010

International Classifications

A01N 43/42 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/47 (2006.01) - Quinolines

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2010/147665 Priority application(s): WO2010/147665

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010260459-Medical device fixation anchor having improved compaction and delivery properties

2010260454-Tunable electro-optic liquid crystal lenses and methods for forming the lenses